Detection of Minimal Residual Disease in the Peripheral Blood of Breast Cancer Patients, with a Multi Marker (MGB-1, MGB-2, CK-19 and NY-BR-1) Assay

PURPOSE: Minimal residual disease (MRD) refers to micrometastases that are undetectable by conventional means and is a potential source of disease relapse. This study aimed to detect the presence of breast cancer (BC) biomarkers (MGB-1, MGB-2, CK-19, NY-BR-1) using real-time polymerase chain reactio...

Descripción completa

Detalles Bibliográficos
Autores principales: Meijer, Suzy E, Klebanov-Akopyn, Olga, Pavlov, Vera, Laks, Shachar, Hazzan, David, Nissan, Aviram, Zippel, Douglas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605792/
https://www.ncbi.nlm.nih.gov/pubmed/34815711
http://dx.doi.org/10.2147/BCTT.S337075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605792/
https://www.ncbi.nlm.nih.gov/pubmed/34815711
http://dx.doi.org/10.2147/BCTT.S337075

Ejemplares similares